The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

How to treat the left main

Bioresorbable vascular scaffolds in left main coronary artery disease

EuroIntervention 2015;11:V135-V138. DOI: 10.4244/EIJV11SVA30

1. Thoraxcenter, Erasmus Medical Centre, Rotterdam, The Netherlands; 2. Cardiovascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy; 3. Fortis Escorts Heart Institute, New Delhi, India

Currently, the use of bioresorbable vascular scaffolds (BRS) for the treatment of left main (LM) coronary artery disease has to be considered investigational. However, some early evidence from case reports supports the feasib

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Is there a need for dedicated devices?